Video Experimental Relacionado
Updated: Sep 9, 2025
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.5K
Consideraciones para el uso de la terapia hormonal en sobrevivientes de cáncer de mama
1Cleveland Clinic, Cleveland, Ohio.
Menopause (New York, N.Y.)
|September 2, 2025
Resumen
El uso de la terapia hormonal en sobrevivientes de cáncer de mama sigue siendo complejo. La falta de datos a largo plazo crea incertidumbre para los pacientes y los médicos con respecto a la seguridad y la calidad de vida.
Área de la Ciencia:
- En el campo de la oncología
- Endocrinología
Sus antecedentes:
- El uso de la terapia hormonal en sobrevivientes de cáncer de mama es controvertido.
- Las guías históricas han advertido contra su uso.
- La seguridad es multifactorial pero los datos oncológicos a largo plazo son limitados.
Objetivo del estudio:
- Para abordar la complejidad y la controversia que rodea la terapia hormonal en sobrevivientes de cáncer de mama.
- Para resaltar la falta de datos oncológicos definitivos a largo plazo.
- Informar la toma de decisiones clínicas en medio de la incertidumbre.
Principales métodos:
- Revisión de la literatura existente y las directrices sobre la terapia hormonal para las sobrevivientes de cáncer de mama.
- Análisis de las implicaciones de los limitados datos oncológicos a largo plazo.
- Discusión sobre la calidad de vida y las preocupaciones de salud.
Principales resultados:
- Los datos oncológicos a largo plazo sobre la terapia hormonal en sobrevivientes de cáncer de mama son insuficientes.
- Las pruebas actuales no proporcionan respuestas definitivas sobre la seguridad.
- La incertidumbre persiste tanto para los pacientes como para los proveedores de atención médica.
Conclusiones:
- Las decisiones relativas a la terapia hormonal deben tomarse basándose en la mejor evidencia imperfecta disponible.
- Se necesita más investigación para establecer la seguridad y eficacia a largo plazo.
- Abordar las preocupaciones de la calidad de vida de los pacientes es primordial.
Videos de Conceptos Relacionados
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:27Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
01:22Target Cell Response to Hormones
3.5K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
3.5K
01:30Hormonal Control of the Ovarian Cycle
2.7K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
2.7K